| Authors: |
Pfeil J; GRC Computational Oncology, AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, CA, 94080, USA. jacob.pfeil@abbvie.com., Ma L; GRC Computational Oncology, AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, CA, 94080, USA., Lo HC; GRC Computational Oncology, AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, CA, 94080, USA., Turan T; GRC Computational Oncology, AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, CA, 94080, USA., McLaughlin RT; GRC Methods Development, AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, CA, 94080, USA., Shi X; GRC Methods Development, AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, CA, 94080, USA., Villarruel S; GRC Computational Oncology, AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, CA, 94080, USA., Wilson S; GRC Computational Oncology, AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, CA, 94080, USA., Zhao X; GRC Computational Oncology, AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, CA, 94080, USA., Samayoa J; GRC Computational Oncology, AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, CA, 94080, USA., Halliwill K; GRC Computational Oncology, AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, CA, 94080, USA. |